Lam Research Corporation $LRCX Shares Bought by Meiji Yasuda Life Insurance Co

Key Points

• Meiji Yasuda Life Insurance Co increased its stake in Lam Research Corporation by 19.5% during the first quarter, owning 19,361 shares valued at approximately $1.41 million.
• Lam Research received several buy rating upgrades from analysts, with target prices ranging from $115 to $120, reflecting strong confidence in the company's performance.
• The company recently announced a dividend increase to $0.26 per share, with a yield of 1.0%, set to be paid on October 15th to investors of record.

Meiji Yasuda Life Insurance Co grew its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 19.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,361 shares of the semiconductor company's stock after purchasing an additional 3,161 shares during the period. Meiji Yasuda Life Insurance Co's holdings in Lam Research were worth $1,408,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Smallwood Wealth Investment Management LLC acquired a new position in shares of Lam Research in the first quarter valued at about $26,000. Mpwm Advisory Solutions LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. Park Square Financial Group LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $31,000. Putney Financial Group LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $36,000. Finally, 1 North Wealth Services LLC purchased a new stake in shares of Lam Research in the first quarter worth about $36,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Price Performance

Shares of NASDAQ LRCX traded up $8.22 during midday trading on Thursday, hitting $115.58. The stock had a trading volume of 20,287,639 shares, compared to its average volume of 10,496,659. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $115.90. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $146.28 billion, a PE ratio of 27.78, a P/E/G ratio of 1.38 and a beta of 1.76. The stock has a 50 day simple moving average of $100.71 and a 200-day simple moving average of $86.43.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. During the same quarter last year, the firm earned $1.03 earnings per share. The business's revenue for the quarter was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be issued a $0.26 dividend. This is a boost from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, September 24th. Lam Research's payout ratio is 25.00%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Oppenheimer upped their target price on Lam Research from $110.00 to $120.00 and gave the stock an "outperform" rating in a research note on Thursday, July 31st. Barclays set a $83.00 target price on Lam Research and gave the stock an "equal weight" rating in a research note on Monday, July 28th. Stifel Nicolaus increased their price target on Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. Mizuho increased their price target on Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research report on Friday, August 1st. Finally, Wells Fargo & Company set a $98.00 price target on Lam Research and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Twenty equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $107.52.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.